跳至主要内容
临床试验/NCT01587378
NCT01587378已完成不适用

A Prospective, Randomized, Double-blind, Multi-centre Study, Where the Possible Effect of Metformin to Prevent Late Miscarriage and Preterm Delivery is Studied in Women With Polycystic Ovary Syndrome (PCOS)

Norwegian University of Science and Technology13 个研究点 分布在 3 个国家目标入组 489 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
489
试验地点
13
主要终点
combined incidence of late miscarriages and preterm births

研究概览

简要总结

The overall aim of the PregMet 2 Study is to investigate whether metformin prevents late miscarriages and preterm deliveries in PCOS women treated with metformin from first trimester of pregnancy to delivery in a large, randomized, controlled, multi-centre trial setting.

The investigators hypothesis is that metformin compared to placebo treatment from the first trimester to term, reduces the prevalence of late miscarriage (gestational week 13-22) and preterm birth (gestational week < 37) in PCOS women diagnosed according to Rotterdam 2003 consensus criteria, with singleton pregnancy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age: 18-45 years
  • PCOS diagnosed or reconfirmed according to Rotterdam 2003 criteria, not more than 5 years prior to inclusion
  • Mode of conception: Any
  • Single, viable fetus, diagnosed by vaginal ultrasound
  • Gestational week at inclusion: week 6 + 0 to 12 + 0
  • Wash out for metformin: at least 7 days
  • Able to communicate fluently in the official language at the study cite or English

排除标准

  • Any type of diabetes (except GDM in former pregnancy)
  • Known liver disease or ALAT > 100 IU/L
  • Known kidney disease or creatinine > 110 μmol/L
  • Known alcohol or drug abuse
  • Use of drugs interfering with metformin: erytromycin (or other macrolides), cimetidine, anticoagulation therapy
  • Unsuitable for participation of other reasons

研究组 & 干预措施

metformin

Experimental

干预措施: Metformin (Drug)

placebo

Placebo Comparator

干预措施: placebo (Drug)

结局指标

主要结局

combined incidence of late miscarriages and preterm births

时间窗: at delivery

This includes spontaneous births, induced vaginal deliveries and operative deliveries on medical indications.

次要结局

  • NICU admissions and total number of days in NICU/baby(2 months)
  • Prevalence of preeclampsia(up to delivery)
  • number of patients hospitalized(at delivery)
  • Prevalence of gestational diabetes(up to delivery)
  • Total number of hospitalization days/ hospitalized participant(2 months)
  • SNP(at delivery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验